Clinical trials in follicular lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for follicular lymphoma patients.

 If you would like to know how to access our trials please click here

 

Trial Name

 

Description

 

Click for more information (external page)

 

GEN3013

 

Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma

Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment

 

 

 

BI 1206 CRUK CD32b

 

Phase 1/2a study looking at blocking the CD32b protein with the antibody BI 1206.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

PARADIGME LYMRIT-37-01

 

A phase 2 trial comparing two different doses of Betalutin and lilotomab

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

PETReA

 

A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymhoma

Suitable for patients who haven't yet received any treatment

 

 

 

MEDI4736 (FUSION)

 

Phase 1-2 study to assess the safety and tolerability of durvalumab, the anti-pd-l1 antibody.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

RiVa

 

Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following: